Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, USA.
The Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery Surgical Outcomes Program, Mayo Clinic, Rochester, MN, USA.
Gynecol Oncol. 2020 Feb;156(2):278-283. doi: 10.1016/j.ygyno.2019.11.007. Epub 2019 Nov 27.
We sought to identify postoperative complications with the greatest impact on patient-centric outcomes to serve as high yield QI targets in ovarian cancer (OC) surgery.
Women undergoing complex CRS (defined as cytoreductive surgery with colon resection) for OC between January 1, 2012 and 12/31/2016 were identified from the National Surgical Quality Improvement Program (NSQIP) database. We determined the population attributable fraction (PAF) to quantify the contribution of each major complication towards adverse outcomes. PAF represents the burden of adverse outcomes that could be eliminated if the corresponding complication was prevented. Organ space surgical site infection (SSI) was used as a surrogate for anastomotic leak (AL).
A total of 1434 women met inclusion criteria. Any adverse clinical outcome (composite of death, reoperation, or end organ dysfunction) occurred in 9.1% of women, and AL was the largest contributor to adverse clinical outcomes [PAF = 33.4% (95%CI: 22.3%-45.6%)]. The rates of increased resource utilization were as follows; prolonged hospitalization in 23.7%, non-home discharge in 10.7% and unplanned readmission in 14.8% of women. AL was the largest contributor to prolonged hospitalizations [PAF = 75.7% (95%CI: 51.4%-90.0%)] and readmissions [PAF = 17.1% (95%CI: 11.5%-22.6%)]; while transfusion was the largest contributor to non-home discharge [PAF = 22.8% (95%CI: 0.7%-42.4%)]. By comparison, the impact of other complications, including those targeted by the Surgical Care Improvement Project (SCIP), such as incisional SSI, venous thromboembolism, myocardial infarction, and urinary infection, was small.
Anastomotic leak is the largest contributor to adverse clinical outcomes and increased resource utilization after complex cytoreductive surgery. Quality improvement efforts to reduce AL and its impact should be of highest priority in OC surgery.
我们旨在确定对患者为中心的结局影响最大的术后并发症,作为卵巢癌(OC)手术中高收益质量改进(QI)的目标。
我们从国家手术质量改进计划(NSQIP)数据库中确定了 2012 年 1 月 1 日至 2016 年 12 月 31 日期间接受复杂的结直肠切除术(CRS)的 OC 患者。我们确定了人群归因分数(PAF)以量化每个主要并发症对不良结局的贡献。PAF 代表如果预防相应的并发症,可以消除的不良结局负担。器官空间手术部位感染(SSI)被用作吻合口漏(AL)的替代指标。
共有 1434 名女性符合纳入标准。任何不良临床结局(死亡、再次手术或终末器官功能障碍的复合结局)在 9.1%的女性中发生,AL 是导致不良临床结局的最大因素 [PAF=33.4%(95%CI:22.3%-45.6%)]。增加资源利用的发生率如下:23.7%的女性住院时间延长,10.7%的女性非居家出院,14.8%的女性非计划再入院。AL 是延长住院时间的最大因素 [PAF=75.7%(95%CI:51.4%-90.0%)]和再入院[PAF=17.1%(95%CI:11.5%-22.6%)];而输血是导致非居家出院的最大因素 [PAF=22.8%(95%CI:0.7%-42.4%)]。相比之下,其他并发症的影响较小,包括 Surgical Care Improvement Project(SCIP)针对的并发症,如切口 SSI、静脉血栓栓塞、心肌梗死和尿路感染。
吻合口漏是复杂减瘤手术后不良临床结局和增加资源利用的最大因素。减少 AL 及其影响的质量改进工作应成为 OC 手术的重中之重。